Open call for presenters in the field of advanced medical technology
Life Science Innovation Network Japan, Inc. (Chairman of the Board: Hideyuki Okano; hereinafter "LINK-J"), Japanese Organization for Medical Device Development, Inc. (CEO: Takahiro Uchida; hereinafter "JOMDD"), MedVenture Partners, Inc. (President & CEO: Takashi Shimada; hereinafter "MedVenture"), and US-Japan Medtech Frontiers (Chairman: Jack Moorman; hereinafter "USJMF") today announced a call for presenters at their annual pitch event.
This pitch event, which has been held on the theme of medical devices and other innovations in medicine, is celebrating its third year. On November 13, 2020, the 3rd MEDTEC INNOVATION Symposium & Pitch will be hosted by LINK-J, with support from JOMDD, MedVenture, and USJMF. (*Symposium summary found at the end of this press release.)
Individuals and teams who passed the document screening will be eligible to participate in the event and pitch their business in front of the jury, which includes Japanese and American medtech venture capitalists. The winning team will receive prizes.
The event is slated to be held in Tokyo and Osaka as main venues, with additional online streaming, allowing it to reach a wider audience than ever before.
Guidelines for applicants : MEDTEC INNOVATION Pitch
|Companies, teams, and individuals (including students) with ideas, technology, products, or a business (unpatented ideas are also accepted) pertaining to medical devices, digital health, medical services, or other medicine and healthcare related technology, and equipped to present it.|
|- Pre-screening: documents will be screened in order to determine final candidates to appear at the pitch event. All applicants will be notified of results; those passing the initial screening will be announced on the LINK-J web site on October 31.
Applications and inquiries:
email@example.com (contact: Takahata, JOMDD)
*Deadline to apply: Friday, September 23
*Please send a summary of your company and technology to the e-mail address above to apply. (Any format is accepted. Consolidate your application under ten pages and list applicant backgrounds and company history, and discuss technical advantage, business innovation, intellectual property, and other details).
- Final screening: during the 3rd MEDTEC INNOVATION Symposium & Pitch on November 13, the jury will review presentations made in either Japanese or English. The results will be announced the same day at the venue. Teams are given 5 minutes to present and 5 minutes for Q&A.
- Venue details: Generally speaking, all presenters will be asked to appear at the Tokyo venue, not Osaka, but this may be changed to streaming online. Details will be finalized in October and notified directly to presenters.
- Jury: selected from venture capitalists in the Japan/US medical devices sector
|The winning team is entitled to select from 1 or 2 below.
1. Travel expenses for an overseas travel program (two members of winning team) focusing on securing interest from Silicon Valley venture capital, incubators, and investors (three nights, five days stay in Silicon Valley).
(Examples of places to visit: U.S. Medical Device Incubator 'Triple Ring Technologies' , Fogarty Institute, UCSF Rosenman Institute, etc)
*Destinations are subject to change.
*The timing of travel will be determined according to conditions surrounding COVID-19.
*If we cannot say for certain about when the trip will be carried out, there is a possibility that we will offer a prize money based on the travel expenses instead of travel expenses.
2. JOMDD will provide up to 100M JPY in commercialization/overseas expansion costs or development costs.
|Flyer||MEDTEC INNOVATION Pitch: Open call for presenters in the field of advanced medical technology (PDF)|
Pitch jury profiles
Founder and CEO of the Japanese Organization for Medical Device Development, Inc. (JOMDD), the first incubator for medical devices and healthcare in Japan. Taka is a specialist for cardiology and internal medicine in Japan. He graduated the Harvard School of Public Health with a master degree in Epidemiology and completed the General Management Program at Harvard Business School. He is the first Japanese medical officer/reviewer at the U.S. Food and Drug Administration, Center for Devices and Radiological Health.
After succeed as a Medical Director at Boston Scientific Corporation, Taka worked as a consultant to support multiple medtech startups in the Bay area of U.S.A.
He also holds several academic roles, for example, committee member/review board/advisory for the Ministry of Health, Labour, and Welfare, Japan Agency for Medical Research and Development, etc.
Born in Hamamatsu City. A doctor of medicine. After graduating from Jichi Medical University, became involved in regional healthcare, such as medical access for those in remote regions. During this time, experienced issues particular to the Japanese medical space, such as its super-aging society. Starting in 2001, began circulatory organ research at the Stanford University department of cardiology, and since that time has contributed to research & development, animal testing, and clinical trials for over 200 American medical device startups over the span of nineteen years. Has played a part in numerous successful startups from their founding, among them Fox Hollow Technologies, Atheromed, KAI Pharmaceutical, and CV Ingenuity. In addition to working with startups, is also an experienced advisor in his field to major medical device manufacturers and other players, and is deeply familiar with medical affairs in Japan and the United States. Since 2013, has served as a board member of MedVenture Partners.
Founder, Silicon Prairie Center
Partner, Nichibei Medtech Advisors, LLC
Board Member, Co-Founder, MedMarket Access, LLC
Kirk Zeller, DBA is a medical device entrepreneur and founder of the Silicon Prairie Center, a unique entrepreneur live and work community which incubates capital efficient start-ups. Kirk's career as well as his masters and doctorate research have focused on medical device start-ups and Kirk is currently co-founder of several companies including two incubated at the Silicon Prairie Center. Kirk started his career as a heart valve sales rep in Japan and has lived, worked, and studied in the US, Europe, and Asia.
Joined Daiichi Pharmaceutical Co., Ltd. (currently: Daiichi Sankyo Co., Ltd.) in 1994. Hasegawa was assigned to the post-marketing surveillance department and took charge of the areas of infectious diseases and oncology. He joined UFJ Capital Co., Ltd. (currently: Mitsubishi UFJ Capital Co., Ltd.) in 2004. Since 2013, he has been engaged in open innovation activities in collaboration with Daiichi Sankyo Co., Ltd. based on the results of academic research funded by the OiDE Fund. Hasegawa has promoted investment efforts using the Mitsubishi UFJ Life Science No.1 Fund, No. 2 Fund and No.3 Fund (MUFG Medical Fund) (total 30 billion yen) established in 2017, 2019 and 2020 respectively. Currently, he is an outside director of Kamui Pharma, Inc., Chordia Therapeutics, Inc., Veritas In Silico, Inc., and GAIA Biomedicine, Inc., as well as a "medical field" industry-academia fellow at the Graduate School of Medicine, Kyoto University, under the Industry-Academia Collaboration Initiative.
Shin leads GLOBIS's investments in consumer and healthcare area. Forbes Japan's Midas List #1 2018. BA in Econmics from University of Tokyo, Harvard Business School MBA.
His track record includes: IPO iStyle, Aucfan, Kayac , Pixta, Mercari, and Lancers; M&A Shimauma Print System, and nanapi. His active portfolio includes Viibar, Timers, Coubic, Reblue, and Mirrative, FastDOCTOR, and Gracia etc.
Outline of 3rd MEDTEC INNOVATION - Symposium and Pitch
Date and Time: Friday, November 13, 2020 1:00PM-7:15PM (6:15PM-7:15PM Mingle session)
Details (tentative): The symposium will feature keynote speeches and panel discussions on themes such as 'Digitization in Medicine, Big Data in Medicine, and the Transformation of Industry and Medicine Transformed by Technology,' with speakers and panelists who are active in the forefront of medical innovation.
For an outline of the pitches, please refer to the attached 'MEDTEC INNOVATION Pitch: open call details'.
Location: the event is slated to be held at a main venue, satellite venue, and streamed online.
◆First venue: Nihonbashi Life Science Hub (Muromachi Chibagin Mitsui Building, 8th Floor (COREDO Muromachi 3), 1-5-5 Nihonbashi Muromachi, Chuo-ku, Tokyo, 103-0022)
◆Second venue: Midosuji Mitsui Building (4-1-3 Bingomachi, Chuo-ku, Osaka-shi, Osaka, 541-0051)
◆Satellite venue: Nihonbashi Life Science Building, Conference Room 201 (2-3-11 Nihonbashi Honmachi, Chuo-ku, Tokyo, 103-0023)
◆Online venue: plans for online streaming/online exhibit
*Note that, depending on conditions surrounding COVID-19, the event may be held fully online.
Hosted by: Life Science Innovation Network Japan, Inc. (LINK-J)
Co-hosted by: Japanese Organization for Medical Device Development, Inc. (JOMDD), MedVenture Partners, Inc., and US-Japan Medtech Frontiers (USJMF)
Slated visitors: members of the media, personnel from the medical devices sector (approx. 150 on-site attendees from Tokyo, Osaka, and approx. 700 global attendees online)
|1:00 PM-2:00 PM||Greeting and Keynote lecture|
|2:00 PM-2:10 PM||Break|
|2:10 PM-3:20 PM||Presentations 1-4|
|3:20 PM-4:20 PM||Panel discussion|
|4:20 PM-4:40 PM||Break|
|4:40 PM-6:15 PM||Pitches
Theme: MEDTEC INNOVATION pitches
Startup pitch (5min) + Q&A (5min) x each team
Jury members: Takahiro Uchida (CEO, JOMDD), Fumiaki Ikeno (MedVenture Director/Founder/Chief Medical Officer), Kirk Zeller (UFJMF), Hiroyuki Hasegawa (Mitsubishi UFJ Capital Executive Officer, Head of Life Science Division), Shin'ichi Takamiya (Managing Partner, Globis Capital Partners)
|6:15 PM-7:15 PM||Mingle session/business card exchange|
*Alongside the discussions above, an online exhibit is also slated to be held (with companies and organizations in the healthcare space acting as exhibitors)
Overview of Life Science Innovation Network Japan, Inc. (LINK-J)
LINK-J is a general incorporated association established by Mitsui Fudosan and volunteers from academic circles. With its base in the Nihonbashi area, where a number of pharmaceutical companies cluster, LINK-J aims to promote open innovation in the life science realm through industry-government-academia cooperation and extend support to the creation of new industries. LINK-J will accelerate interdisciplinary exchanges at human/ technology field, where all sciences are combined, ranging from medicine to science, further more, engineering, new technologies, such as information and communication technology (ICT) or artificial intelligence (AI).
Overview of Japanese Organization for Medical Device Development, Inc. (JOMDD)
Japanese Organization for Medical Device Development, Inc. is the first business incubator in Japan that cooperates with academia and startups in Japan to commercialize medical devices and other products. It invests money in and provides support to research institutions and businesses around Japan to grow Japan-made products that can compete globally; for example, the outsourcing of projects of the Japan Medical Association, universities, and local administrations such as Kanagawa and Kobe. Its' track record includes investment in and support for the start-up from Kumamoto that is developing a pain treatment device and the start-up from the University of Electro-Communications that is developing rehabilitation equipment and other devices using robotics technology.
Overview of MedVenture Partners, Inc.
MedVenture Partners, Inc. invests in the life science field, including medical devices, at an early stage so as to contribute to the development of the medical device business incubation and the industrial base for medical Device in Japan through a sufficient track record of investment in medical device start-ups and business incubation in Japan and the U.S.A., includingSilicon Valley, experience in clinical settings and medical research in Japan, and their global network.
The first fund have already produced four successful cases,Biomedical Solutions Inc, Arrinex, Inc, etc.
Overview of US-Japan Medtech Frontiers(USJMF)
USJMF is a nonprofit corporation based in Silicon Valley whose mission is to share best practices for medical device innovation and promote networking and cooperation between US and Japanese medical device organizations.
■Inquiries about this release■
Japanese Organization for Medical Device Developement, Inc. (JOMDD)
Telephone: 03-6262-3322 Facsimile: 03-6262-3022
PR personnel: Takahata